Stock NTRB NUTRIBAND INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Nutriband Inc.

Equities

NTRB

US67092M2089

Market Closed - OTC Markets
Other stock markets
 04:30:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
4.77 USD -2.05% Intraday chart for Nutriband Inc. -5.54% +105.60%
May. 16 Nutriband Inc. Appoints Sergei Glinka to Its Board of Directors CI
May. 01 Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
AQ
Nutriband Inc. Appoints Sergei Glinka to Its Board of Directors
CI
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
CI
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
CI
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
CI
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
CI
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch through FDA Submission
AQ
IBN Coverage Initiated for Nutriband Inc.
AQ
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
AQ
Nutriband Inc. Closes $8.4 Million Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
CI
Nutriband Inc. announced that it expects to receive $8.4 million in funding
CI
Nutriband Inc. Announces $8.4M Private Placement
AQ
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
AQ
Nutriband Inc. Receives First Order from Fit for Life Group
CI
Nutriband Inc. Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
CI
Nutriband Inc. Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented At 2024 American Academy of Pain Medicine Annual Meeting
CI
Nutriband Inc. Announces Data on the Incidence of Transdermal Patch Abuse and Accidental Pediatric Exposure Will Be Presented At the 2024 American Academy of Pain Medicine Annual Meeting
CI
Nutriband Inc. to Present at the Microcap Conference Atlantic City January 30th through February 1st
AQ
Nutriband CEO Publishes Letter to Shareholders
AQ
Nutriband Signs Agreement With Kindeva Drug Delivery for Aversa Fentanyl
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NTRB Stock
  4. News Nutriband Inc.